Factory:

Regd. Office : 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : (+91) (22) 42160000/ 28505387 • FAX. : (+91) (22) 28563930, Email: info@blissgvs.com •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771

Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. •Email: factory@blissgvs.com

Encl: As above

Company Secretary

Yours faithfully, For Bliss GVS Pharma Limited

Thanking you.

Kindly take the same on record.

Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the quarter and nine months ended December 31, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on February 13, 2020.

Dear Sir/ Madam,

Subject: Newspaper Advertisement of Unaudited Financial Results for the quarter and nine months ended December 31, 2019

To The General Manager, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 506197

To The Manager, Listing Deparhnent National Stock Exchange of India Plot no. C/1 G Block, Bandra-Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: BLISSGVS

February 13, 2020

BLISS GVS PHARMA LTD.

11 I

EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2019

({ In Lakhs)

STANDALONE CONSOLIDATED

QUARTER NINE MONTHS YEAR QUARTER QUARTER NINE MONTHS YEAR QUARTER

Particulars ENDED ENDED ENDED ENDED ENDED ENDED ENDED ENDED 31.12.2019 31.12.2019 31.03.2019 31.12.2018 31.12.2019 31.12.2019 31.03.2019 31.12.2018

(UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED)

Total income from operations (net) 12,481.60 34,;398.20 42,659.02 9,563.20 14,784.89 56,950.51 89,824.92 22,043.48

Net Profit I (Loss) from ordinary activities after tax 2,355.52 7,591.37 7,443.39 1,170.07 2,545.14 8,968.14 12,666.27 2,722.87

Net Profit/ (Loss) from ordinary activities after tax, 2,355.52 7,591.37 7,443.39 1, 170.07 2,545.14 8,968.14 12,666.27 2,722.87 exceptional and extraordinary items

Total Comprehensive lncomeforthe period 2,354.84 7,589.27 7,426.03 1,171.55 2,287.58 9,098.62 12,464.54 2,413.26

Equity Share Capital 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47

Other Equity 59,295.89 63,568.39

Earnings Per Share 2.28 7.36 7.22 1.13 2.30 8.58 11.99 2.50

Basic and Diluted (in Rs.)

Note: (1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter and Nine Months ended December 31, 2019 and Annual Result for the Year ended March 31, 2019 filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures for the quarter ended December 31, 2019 are the balancing figures between the unaudited figures in respect of the nine months ended December 31, 2019 and half year ended September 30, 2019." (2) The full format of the Standalone and Consolidated financial results for the Quarter and Nine months ended December 31, 2019 and Annual Result for the Year ended March 31, 2019 are available on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com. (3) The results have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under section 133 of the Companies Act read with relevant rules issued there under.

For and on behalf of the Board of Directors -· SD/-

Place : Mumbai S. N. KAMATH Date : February 11, 2020 MANAGING DIRECTOR .. ~· ~- . '· ..., - ~-

Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072. • Tel: 022-42160000 • Fax: 022-28563930 • Email: info@blissgvs.com • Website: www.blissgvs.com

BLISS GVS PHARMA LIMITED CIN No.- L24230MH1984PLC034771

:1. _ THE ECONOMIC TIMES I MUMBAI I THURSDAY I 13 FEBRUARY 2020 I WWW.ECONOMlCTIMES.COM

EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2019

. . . . .. . . . . . . . . . .. . ... . ' . . · . . .

(fin Lakhs)

STANDALONE CONSO.LIDATED

QUARTER NINEMQNTHS YEAR QUARTER QUARTER'· NINE MONTHS YEAR QUARTER

Particulars ENDED ENDED ENDED ENDED ENDED ENDED ENDED ENDED 31.12.2019 31.12.2019 31.03.2019 31.12.2018 31.12.2019 31.12.2019 31.03.2019 31.12.2018

(UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED)

Total income from operations (net) 12,481.60 34,398.20 42,659.02 9,563.20 14,784.89. 56,950.51 89,824.92 22,043.48 ,...

Net Profit I (Loss) from ordinary activities after tax 2,355.52 7,591.37 7,443.39 1,1°70.07 2,545.14 8,968.14 12,666.27 :p22.87 '. \-

2,545.14 Net Profit/ (Loss) from ordinary activities after tax, 2,355.52 7,591.37 7,443.39 1,170.07 ·8,968.14 . 12,666.27 .: 2,722.87 --e:iEceptional and extraordinary items "" . - . . . 'c .. ·- - ~ -

Total Comprehensive Income for the period 2;354:84 7,5!!9.27 7,426.03 1;171.65 · 2,287.58 · 9,098.62 12.~64.54 2,413.26

Equity Share Capital 1,031.47 1,031.47 1,031.47 1,031.47 i ,031.47 1,031.47 1,031.47 1,031.47

Other Equity 59,295.89 63,568.39

Earnings Per Share 2.28 7.36 7.22 1.13 2.30 8.58 11.99 2.50

Basic and Diluted (in Rs.)

Note: '

(1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter and Nine Months ended December 31, 2019 and Annual Result for the Year ended March 31, 2019 filed with the Stock Exchanges under Regulation 33 o!the SEBI (Listing Obligations and Disclosure . Requirements) Regulations, 2015. The figures for the quarter ended December 31, 2019 are the balancing figures between the unaudited figures in respect of the

;- nine months ended December 31, 2019 and half year ended Septemb_er30, 2019." (2) The full format of the Standalone and Consolidated financial results for the Quarter and Nine months ended December 31, 2019 and Annual Result for the Year , ended March 31, 2019 are available on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com. (3) The results have been prepared in accordance with the Indian Accounting Standards (Ind AS} as prescribed under section 133 of the Companies Act read with relevant rules issued there under.

For and on behalf ofthe Board of Directors SD/- ..

Place : Mumbai S.N. KAMATH Date : February 11, 2020 MANAGING DIRECTOR

·-· . .

BL'ISS GVS PHARMA LIMITED_ ciN No.- L24239MH198'4PLC0347i1

Registered Office: 102, Hyde Park, SakiVihar Road, Andhert (East), Mumbai - 400 072. • Tel: 022-42f60000 • Fax: 022-28563930 • Email: info~blissgvs.com • Website: WWVJ.blissgvs.com

~===-====------'-------=======-· I •....•.....• .s:

www.freepressjo' nal.in

1·

EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2019

- ' (tin Lakhs) STANDALONE

. CONSOUDATED I

I

QUARTER NINE MONTHS YE~R QUARTER QUARTER NINE MONTHS YEAR QUARTER I

Particulars ENDED ENDED ENDED. ENDED ENDED ENDED ENDED ENDED 31.12.2019 31.12.2019 · 31.03.2019 31.12.2018 31.12.2019 31.12.2019 31.03.2019 31.12.2018

(UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED) '(UNAUDITED)· (UNAUDITED) (AUDITED) (UNAUDITED)

Total income from operations (net) 12,481.60 34,398.20 42,659.0f 9,'563.20 14,784.89 56,950.51 89,824.92 22,043.48

Net Profit/ (Loss) from ordinary activities after tax 2,355.52 7,591.37 '7,443.39 1, 170.07 2,545.J4 8,968.14 12,666.27 2,722.87

Net Profit/ (Loss) frdm ordinary activities after tax, 2,355.52 7,591.37 7,443:39 1,170.07 2;545.14 8,968.14 12,666.27 2,722.87 I

exceptional and extraordinary items II Total Comprehensive Income for the period 2,354.84 7,589.27 . 7,426.03 1, 171.55 2,287.58 9,098.62 12,464.54 2,413.26 J

Equity Share Capital ·1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 ·1,031.47 1,031.47 1,031.471

Other ~quity ' 59°,295.89 63,568.39

Earnings Per Share 2.28 7.36 7.22 r13 2.30 8.58 11.99 2.50

Basic and Diluted (in Rs.) . ' ~ - . I

N_ote: .,

' (1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter and Nine Month_s ended December 31, 2019 and Annual Resultforthe Year ended March 31, 2019 filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures for the quarter ended December 31, 2019 are the balancing fiquresbetween the unaudited figures in respect of the nine months ended December 31, 2019 and half year ended September 30, 2019." (2) The full format of the Standalone and Consolidated financial results for the Quarter and Nine months ended December 31 , 2019 and Annual Result for the Year

. I • ended March 31, 2019 are available on the Stock Exchange websites - www.bsetndla.com and www.riseindia.com and on the Company's website. www.blissgvs.com. (3) The results have been prepared in accordance with the Indian Accounting Standards (Ind A?) as prescribed under section 133 of the Companies Act read with relevant rules issued there under. .

- '

- For and on behalf of the Board ot Directors ' SD/-

Place : Mumbai·. S. N. KAMATH Date : February 11, 2020 MANAGING DIRECTOR ,:·

Registered Office: 102,'Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072. • Tel: 022-42160000, • Fax: 022-28563930 • Email: info(§?bl~ssgvs.com • Website: wwwbhssqvs.corn

a·LISS ·GV.S PHARMA LIMITED CIN No.- L24230MH1984PLC034771

. 1 •:

EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED DECEMBER 31, 2019

.'?' .. (t in Lakhs), I

STANDALONE CONSOLIDATED

QUARTER NINE MONTHS YEAR QUARTER QUARTER NINE MONTHS YEAR QUARTE~

Particulars ENDED ENDED ENDED ENDED ENDED ENDED ENDED ENDED

31.12.2019 31.12.2019 31.03.2019 31.12.2018 31.12.2019 31.12.2019 31.03.2019 31.12.2018 (UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDITED), (UNAUDITED) (UNAUDITED) (AUDITED) (UNAUDIT~D)

Total income from operations (net)' 12,481.60 34,398.29 42,659.02, 9,563.20 14,784.89 56,950.51 89,824.92 ,22,043.48

Net Profit/ (Loss) from ordinary activities after tax 2,355.52 7,591.37 7,443.39 1,170.07 2,545.14 8,968.14 12,666.27 2,722.87 , .

Net Profit/·(Loss) from ordinary activities after tax, 2,355.52 7,591.37 7,443.39 1,170.07 2,545.14 .8,968.14 12,666.27 2,722.87 exceptional and extraordinary items

Total Comprehensive Income for the.period 2,354.84 7,589.27 7,426.03 1, 171.55 2,287.58 9,098.62 12,464.54 2,413.26

Equity Share Capital 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47 1,031.47

Other.Equity I 59,295.89 63,568.39 .. Earnings Per Share

' 2.28 7.36 7.22 1.13 2.30 8.58 11.99 2.50 Basic and pi luted (in Rs.)

' ,, .. - Note:

··ffl"tf~~)lPPJ'C.lf.iis:,an extract of the det~iled format oft ~tf~-~~9he~~WO~~i>lrd~~f~'a~~i(jl:r~cilts_f~".'~e-~~a~eraii~,~-i~e-~ont~s.e~de~ Dece~_bef~, 1i;,eW·l~11M1m!;1fll~ij%lt,ltJeri~1t.'!;~P,t'i1~~Ejl,%M~J~}~J' 201 ftl ct with tfte SloeR'!Exc~a~~§ltinaerRe~ulati?fi 33Jof_ttje S~BI ([1stiffg.?bli~at1ons ~~ttlitcl<l1s~ I

Requirements) Regulations, 201'5. The figures for the quarter ended Decefnbe(3·i, 2019 are the'l5alaiic1ng figures between the unauditea figures in t;~spect of the nine months ended December 31, 2019 and half year ended September 30, 2019." ' " · (2) The full format of the Stang.alone and Consolidated financial results for the Quarter and Nine months ended December 31, 2019 and Annual Result for the Year ended · Mar.ch 31, ·2019 are ·1:_vailable on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com. . >' ·». (3) The results have been prepared in a~~·orcj,ance with the Indian Accounting Standards (Ind AS) as prescribed under section 133 of the Companies Act read with relevant rules issued there under. - ·~

'. .. ". ... I

r ... • ':,

: f:-, •., ?r\. _., ,, For and on behalf of the Board of Directors

"· . "J"·pj:,,:)i:; . . ~ ~; ·. < ' ' .,,

' SD/- .. .. .,

Pia~~: '!'.Mumbai .. - ,; .. ,·;,,. ~ -~· .. S. N. KAMATH

Date : Febru~ry 11, 2020 •.' ' ~ ' -, MANAGING DIRECTOR . >,

- ... --- - .. -

BL.155 GVS PHARMA LIMITED CIN No.- L24230MH1984PLC034771 ·

,._;i,·.: ; :• 'i Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072: : .... • .Tel: 022-42160000 • Fax: 022-28563930 • Em~il: info@bli~sgvs:com ~ Website: www.blissqvs.com

'I